7-12 Dimethylbenz[a]anthracene-induced bone marrow hypocellularity is dependent on signaling through both the TNFR and PKR

Toxicology and Applied Pharmacology

Volumn 198, Issue 1, 2004, Pages 21-28

  Page, Todd J ^a   MacWilliams, Peter S ^a   Suresh, M ^a   Jefcoate, Colin R ^a   Czuprynski, Charles J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bone marrow; DMBA; Immunotoxicity; PAH; PKR; TNF

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; DIMETHYLBENZ[A]ANTHRACENE; GAMMA INTERFERON; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW DISEASE; BONE MARROW HYPOCELLULARITY; BONE MARROW TOXICITY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; INJECTION; MALE; MOLECULAR MECHANICS; MOLECULE; MOUSE; NONHUMAN; PROTECTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BONE MARROW; CARCINOGENS; EIF-2 KINASE; FEMALE; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

MURINAE; MUS MUSCULUS;

EID: 2942748407     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2004.02.014     Document Type: Article

References (54)

1. Bandyopadhyay S.K., de La Motte C.A., Williams B.R. Induction of E-selectin expression by double-stranded RNA and TNF-alpha is attenuated in murine aortic endothelial cells derived from double-stranded RNA-activated kinase (PKR)-null mice. J. Immunol. 164:2000;2077-2083
2. Brown D.M., Donaldson K., Borm P.J., Schins R.P., Dehnhardt M., Gilmour P., Jimenez L.A., Stone V. Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles. Am. J. Physiol.: Lung Cell. Mol. Physiol. 286(2):2004;L344-L353
3. Campbell C.E., Kuriyan N.P., Rackley R.R., Caulfield M.J., Tubbs R., Finke J., Williams B.R. Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma. Int. J. Cancer. 78:1998;182-188
4. Casale G.P., Cheng Z., Liu J., Cavalieri E.L., Singhal M. Profiles of cytokine mRNAs in the skin and lymph nodes of SENCAR mice treated epicutaneously with dibenzo[a, l]pyrene or dimethylbenz[a]anthracene reveal a direct correlation between carcinogen-induced contact hypersensitivity and epidermal hyperplasia. Mol. Carcinog. 27:2000;125-140
5. Cuddihy A.R., Wong A.H., Tam N.W., Li S., Koromilas A.E. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene. 18:1999;2690-2702
6. Davis D.A., Burchiel S.W. Inhibition of calcium-dependent pathways of B-cell activation by DMBA. Toxicol. Appl. Pharmacol. 116(2):1992;202-208
7. Fotin-Mleczek M., Henkler F., Samel D., Reichwein M., Hausser A., Parmryd I., Scheurich P., Schmid J.A., Wajant H. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J. Cell Sci. 115:2002;2757-2770
8. Gale M. Jr., Katze M.G. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:1998;29-46
9. Gersuk G.M., Beckham C., Loken M.R., Kiener P., Anderson J.E., Farrand A., Troutt A.B., Ledbetter J.A., Deeg H.J. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Br. J. Haematol. 103:1998;176-188
10. Gil J., Esteban M. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene. 19:2000;3665-3674
11. Gravestein L.A., Borst J. Tumor necrosis factor receptor family members in the immune system. [comment] Semin. Immunol. 10:1998;423-434
12. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340
13. Haque S.J., Harbor P., Tabrizi M., Yi T., Williams B.R. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 273:1998;33893-33896
14. Heidel S.M., Holston K., Buters J.T., Gonzalez F.J., Jefcoate C.R., Czupyrynski C.J. Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7, 12-dimethylbenz[a]anthracene. Mol. Pharmacol. 56:1999;1317-1323
15. Heidel S.M., MacWilliams P.S., Baird W.M., Dashwood W.M., Buters J.T., Gonzalez F.J., Larsen M.C., Czuprynski C.J., Jefcoate C.R. Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7, 12-dimethylbenz[a]anthracene. Cancer Res. 60:2000;3454-3460
16. House R.V., Lauer L.D., Murray M.J., Dean J.H. Suppression of T-helper cell function in mice following exposure to the carcinogen 7, 12-dimethylbenz[a]anthracene and its restoration by interleukin-2. Int. J. Immunopharmacol. 9(1):1987;89-97
17. Jacobsen S.E., Jacobsen F.W., Fahlman C., Rusten L.S. TNF-alpha, the great imitator: role of p55 and p75 TNF receptors in hematopoiesis. Stem Cells. 12:1994;111-126. (discussion 126-118)
18. Jensen B.A., Leeman R.J., Schlezinger J.J., Sherr D.H. Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study. Environ. Health. 2(1):2003;16
19. Kern P.A., Dicker-Brown A., Said S.T., Kennedy R., Fonseca V.A. The stimulation of tumor necrosis factor and inhibition of glucose transport and lipoprotein lipase in adipose cells by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Metabolism. 51(1):2002;65-68
20. Kerzic P.J., Pyatt D.W., Zheng J.H., Gross S.A., Le A., Irons R.D. Inhibition of NF-kappaB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-alpha-induced apoptosis. Toxicology. 187:2003;127-137
21. Kimber I., Dearman R.J. Immune responses: adverse versus non-adverse effects. Toxicol. Pathol. 30:2002;54-58
22. Kitagawa M., Saito I., Kuwata T., Yoshida S., Yamaguchi S., Takahashi M., Tanizawa T., Kamiyama R., Hirokawa K. Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes. Leukemia. 11:1997;2049-2054
23. Korth M.J., Katze M.G. Evading the interferon response: hepatitis C virus and the interferon-induced protein kinase, PKR. Curr. Top. Microbiol. Immunol. 242:2000;197-224
24. Lang D.S., Becker S., Devlin R.B., Koren H.S. Cell-specific differences in the susceptibility of potential cellular targets of human origin derived from blood and lung following treatment with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). Cell Biol. Toxicol. 14:1998;23-38
25. Lapidot T., Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp. Hematol. 30:2002;973-981
26. Laupeze B., Amiot L., Sparfel L., Le Ferrec E., Fauchet R., Fardel O. Polycyclic aromatic hydrocarbons affect functional differentiation and maturation of human monocyte-derived dendritic cells. J. Immunol. 168(6):2002;2652-2658
27. Lotem J., Sachs L. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene. 21:2002;3284-3294
28. Luster M.I., Simeonova P.P., Gallucci R., Matheson J. Tumor necrosis factor alpha and toxicology. Crit. Rev. Toxicol. 29:1999;491-511
29. Mann K.K., Matulka R.A., Hahn M.E., Trombino A.F., Lawrence B.P., Kerkvliet N.I., Sherr D.H. The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]anthracene-induced pre-B lymphocyte apoptosis. Toxicol. Appl. Pharmacol. 161(1):1999;10-22
30. Moore R.J., Owens D.M., Stamp G., Arnott C., Burke F., East N., Holdsworth H., Turner L., Rollins B., Pasparakis M., Kollias G., Balkwill F. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. [erratum appears in Nat. Med., 5 (9) (1999 Sep.) 1087] Nat. Med. 5:1999;828-831
31. Mundle S.D., Reza S., Ali A., Mativi Y., Shetty V., Venugopal P., Gregory S.A., Raza A. Correlation of tumor necrosis factor alpha (TNF alpha) with high caspase 3-like activity in myelodysplastic syndromes. Cancer Lett. 140:1999;201-207
32. Murata M., Nishimura N., Zhang B., Satoh M., Tohyama C. Interleukin-6 protects skin lesion caused by 7, 12-dimethylbenz[a]anthracene. J. Vet. Med. Sci. 65(4):2003;511-513
33. Okey A.B., Vella L.M. Elevated binding of 2, 3, 7, 8-tetrachlorodibenzo- p-dioxin and 3-methylcholanthrene to the Ah receptor in hepatic cytosols from phenobarbital-treated rats and mice. Biochem. Pharmacol. 33(4):1984;531-538
34. Okey A.B., Dube A.W., Vella L.M. Binding of benzo(a)pyrene and dibenz(a, h)anthracene to the Ah receptor in mouse and rat hepatic cytosols. Cancer Res. 44(4):1984;1426-1432
35. Oono H., Nakagawa M., Miyamoto A., Ishiguro S., Nishio A. Mechanisms underlying the enhanced elevation of IL-1beta and TNF-alpha mRNA levels following endotoxin challenge in rat alveolar macrophages cultured with low-Mg2+ medium. Magnes. Res. 15(3-4):2002;153-160
36. Page T.J., O'Brien S., Jefcoate C.R., Czuprynski C.J. 7, 12-Dimethylbenz[a]anthracene induces apoptosis in murine pre-B cells through a caspase-8-dependent pathway. Mol. Pharmacol. 62:2002;313-319
37. Page T.J., O'Brien S., Holston K., MacWilliams P.S., Jefcoate C.R., Czuprynski C.J. 7, 12-Dimethylbenz[a]anthracene-induced bone marrow toxicity is p53-dependent. Toxicol. Sci. 74:2003;85-92
38. Pallardy M.J., House R.V., Dean J.H. Molecular mechanism of 7, 12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway. Mol. Pharmacol. 36(1):1989;128-133
39. Papadaki H.A., Kritikos H.D., Gemetzi C., Koutala H., Marsh J.C., Boumpas D.T., Eliopoulos G.D. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood. 99:2002;1610-1619
40. Salas V.M., Burchiel S.W. Apoptosis in Daudi human B cells in response to benzo[a]pyrene and benzo[a]pyrene-7, 8-dihydrodiol. Toxicol. Appl. Pharmacol. 151(2):1998;367-376
41. Sawanobori M., Yamaguchi S., Hasegawa M., Inoue M., Suzuki K., Kamiyama R., Hirokawa K., Kitagawa M. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Leuk. Res. 27:2003;583-591
42. Scott K.A., Moore R.J., Arnott C.H., East N., Thompson R.G., Scallon B.J., Shealy D.J., Balkwill F.R. An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther. (5):2003;445-451
43. Srivastava S.P., Davies M.V., Kaufman R.J. Calcium depletion from the endoplasmic reticulum activates the double-stranded RNA-dependent protein kinase (PKR) to inhibit protein synthesis. J. Biol. Chem. 270(28):1995;16619-16624
44. Tartaglia L.A., Pennica D., Goeddel D.V. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:1993;18542-18548
45. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O., Lapidot T., Soffer D., Sobe T., Avraham K.B., Goncharov T., Holtmann H., Lonai P., Wallach D. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:1998;267-276
46. Wang D., Pedraza P.L., Abdullah H.I., McGiff J.C., Ferreri N.R. Calcium-sensing receptor-mediated TNF production in medullary thick ascending limb cells. Am. J. Physiol.: Renal, Fluid Electrolyte Physiol. 283(5):2002;F963-F970
47. White K.L. Jr., Lysy H.H., Holsapple M.P. Immunosuppression by polycyclic aromatic hydrocarbons: a structure-activity relationship in B6C3F1 and DBA/2 mice. Immunopharmacology. 9(3):1985;155-164
48. White K.L., Kawabata T.T., Ladics G.S. Mechanisms of polycyclic aromatic hydrocarbon immunotoxicity. Dean J.H., Luster M.I. Immunotoxicology and Immunopharmacology. 1994;123-143 Raven Press, New York. Chapter 7
49. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene. 18:1999;6112-6120
50. Yang Y.L., Reis L.F., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B.R., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:1995;6095-6106
51. Yeung M.C., Liu J., Lau A.S. An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc. Natl. Acad. Sci. 93:1996;12451-12455
52. Zeytun A., McKallip R.J., Fisher M., Camacho I., Nagarkatti M., Nagarkatti P.S. Analysis of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced gene expression profile in vivo using pathway-specific cDNA arrays. Toxicology. 178(3):2002;241-260
53. Zhaorigetu S., Yanaka N., Sasaki M., Watanabe H., Kato N. Silk protein, sericin, suppresses DMBA-TPA-induced mouse skin tumorigenesis by reducing oxidative stress, inflammatory responses and endogenous tumor promoter TNF-alpha. Oncol. Rep. 10(3):2003;537-543
54. Zhu J., Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 21:2002;3295-3313